Cutler Group LP Chembio Diagnostics, Inc. Transaction History

Cutler Group LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	SELL	$0.25 - $0.45 $77 - $139	-310 Reduced 15.42%	1,700 $0
Q4 2022 Feb 07, 2023	SELL	$0.2 - $0.33 $30 - $50	-152 Reduced 7.03%	2,010 $0
Q3 2022 Oct 25, 2022	SELL	$0.35 - $1.1 $487 - $1,533	-1,394 Reduced 39.2%	2,162 $0
Q2 2022 Aug 04, 2022	BUY	$0.45 - $0.8 $17 - $30	38 Added 1.08%	3,556 $2,000
Q1 2022 Apr 14, 2022	SELL	$0.66 - $1.23 $10,233 - $19,072	-15,506 Reduced 81.51%	3,518 $2,000
Q4 2021 Jan 18, 2022	SELL	$1.09 - $2.55 $28,224 - $66,029	-25,894 Reduced 57.65%	19,024 $21,000
Q3 2021 Oct 26, 2021	BUY	$2.06 - $5.34 $91,501 - $237,192	44,418 Added 8883.6%	44,918 $112,000
Q2 2021 Jul 19, 2021	SELL	$2.88 - $5.64 $12,384 - $24,252	-4,300 Reduced 89.58%	500 $1,000
Q1 2021 Apr 26, 2021	SELL	$3.4 - $7.97 $8,496 - $19,917	-2,499 Reduced 34.24%	4,800 $16,000
Q4 2020 Jan 21, 2021	SELL	$4.11 - $7.51 $7,196 - $13,150	-1,751 Reduced 19.35%	7,299 $34,000
Q3 2020 Oct 27, 2020	SELL	$3.28 - $5.93 $10,082 - $18,228	-3,074 Reduced 25.35%	9,050 $43,000
Q2 2020 Jul 22, 2020	BUY	$3.18 - $15.54 $38,554 - $188,406	12,124 New	12,124 $39,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.